HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2,2,4,4-tetramethylpiperdine-1-oxyl

Also Known As:

TEMPO 2

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Heterocyclic Oxides
  - Cyclic N-Oxides: 3
    - 2,2,4,4-tetramethylpiperdine-1-oxyl: 1

Related Diseases

1.

Polycystic Kidney Diseases (Polycystic Kidney Disease)

06/01/2023 - "TEMPO 2:4 (NCT00413777); phase 1 tolvaptan trial (no NCT number; trial number 156-06-260); phase 2 tolvaptan trial (NCT01336972); TEMPO 4:4 (NCT01214421); REPRISE (NCT02160145); long-term tolvaptan safety extension trial (NCT02251275); OVERTURE (NCT01430494); HALT Progression of Polycystic Kidney Disease (HALT-PKD) study B (NCT01885559)."

Related Drugs and Biologics

1.	Tolvaptan
2.	TEMPO